These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32952937)

  • 1. Designing custom CRISPR libraries for hypothesis-driven drug target discovery.
    Iyer VS; Jiang L; Shen Y; Boddul SV; Panda SK; Kasza Z; Schmierer B; Wermeling F
    Comput Struct Biotechnol J; 2020; 18():2237-2246. PubMed ID: 32952937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generating Custom Pooled CRISPR Libraries for Genetic Dissection of Biological Pathways.
    Gulbranson DR
    Methods Mol Biol; 2022; 2473():333-347. PubMed ID: 35819774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9 for medical genetic screens: applications and future perspectives.
    Xue HY; Ji LJ; Gao AM; Liu P; He JD; Lu XJ
    J Med Genet; 2016 Feb; 53(2):91-7. PubMed ID: 26673779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.
    Joung J; Konermann S; Gootenberg JS; Abudayyeh OO; Platt RJ; Brigham MD; Sanjana NE; Zhang F
    Nat Protoc; 2017 Apr; 12(4):828-863. PubMed ID: 28333914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR screen in cancer: status quo and future perspectives.
    He C; Han S; Chang Y; Wu M; Zhao Y; Chen C; Chu X
    Am J Cancer Res; 2021; 11(4):1031-1050. PubMed ID: 33948344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation libraries for robust RNA interference-based genome-wide screens.
    Kampmann M; Horlbeck MA; Chen Y; Tsai JC; Bassik MC; Gilbert LA; Villalta JE; Kwon SC; Chang H; Kim VN; Weissman JS
    Proc Natl Acad Sci U S A; 2015 Jun; 112(26):E3384-91. PubMed ID: 26080438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic screens and functional genomics using CRISPR/Cas9 technology.
    Hartenian E; Doench JG
    FEBS J; 2015 Apr; 282(8):1383-93. PubMed ID: 25728500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Based Lentiviral Knockout Libraries for Functional Genomic Screening and Identification of Phenotype-Related Genes.
    Thomsen EA; Mikkelsen JG
    Methods Mol Biol; 2019; 1961():343-357. PubMed ID: 30912056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer CRISPR Screens In Vivo.
    Chow RD; Chen S
    Trends Cancer; 2018 May; 4(5):349-358. PubMed ID: 29709259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrayed CRISPR screen with image-based assay reliably uncovers host genes required for coxsackievirus infection.
    Kim HS; Lee K; Kim SJ; Cho S; Shin HJ; Kim C; Kim JS
    Genome Res; 2018 Jun; 28(6):859-868. PubMed ID: 29712754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.
    Shifrut E; Carnevale J; Tobin V; Roth TL; Woo JM; Bui CT; Li PJ; Diolaiti ME; Ashworth A; Marson A
    Cell; 2018 Dec; 175(7):1958-1971.e15. PubMed ID: 30449619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screens in mammalian cells using the CRISPR-Cas9 system.
    Peng J; Zhou Y; Zhu S; Wei W
    FEBS J; 2015 Jun; 282(11):2089-96. PubMed ID: 25731961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi/CRISPR Screens: from a Pool to a Valid Hit.
    Schuster A; Erasimus H; Fritah S; Nazarov PV; van Dyck E; Niclou SP; Golebiewska A
    Trends Biotechnol; 2019 Jan; 37(1):38-55. PubMed ID: 30177380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The applications of CRISPR screen in functional genomics.
    Qi X; Zhang J; Zhao Y; Chen T; Xiang Y; Hui J; Cai D; Liu Y; Xia L; Yu T; Li G
    Brief Funct Genomics; 2017 Jan; 16(1):34-37. PubMed ID: 27329784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multiplexed CRISPR targeting platforms.
    Cao J; Xiao Q; Yan Q
    Drug Discov Today Technol; 2018 Aug; 28():53-61. PubMed ID: 30205881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes.
    Humphrey SE; Kasinski AL
    J Hematol Oncol; 2015 Apr; 8():31. PubMed ID: 25888285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoding the noncoding genome via large-scale CRISPR screens.
    Shukla A; Huangfu D
    Curr Opin Genet Dev; 2018 Oct; 52():70-76. PubMed ID: 29913329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CRISPR/Cas systems in genome engineering of bacteriophages].
    Liang CJ; Meng FM; Ai YC
    Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-content CRISPR screening in tumor immunology.
    Holcomb EA; Pearson AN; Jungles KM; Tate A; James J; Jiang L; Huber AK; Green MD
    Front Immunol; 2022; 13():1041451. PubMed ID: 36479127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.